COVID-19: The Need for Immunoprevention at Industrial Scale.
作者信息
Halstead Scott B
机构信息
Consultant, North Bethesda, Maryland.
出版信息
Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.
Abstract
摘要
相似文献
1
COVID-19: The Need for Immunoprevention at Industrial Scale.
Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.
2
An Urgent Need for "Common Cold Units" to Study COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1152-1153. doi: 10.4269/ajtmh.20-0246.
3
All together to Fight COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1181-1183. doi: 10.4269/ajtmh.20-0281.
4
COVID-19: Small-Molecule Clinical Trials Landscape.
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
5
COVID-19: endgames.
Lancet Infect Dis. 2020 May;20(5):511. doi: 10.1016/S1473-3099(20)30298-X. Epub 2020 Apr 17.
6
Combination prevention for COVID-19.
Science. 2020 May 8;368(6491):551. doi: 10.1126/science.abc5798.
7
The Wuhan SARS-CoV-2-What's next for China.
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
8
The race against COVID-19.
Nat Nanotechnol. 2020 Apr;15(4):239-240. doi: 10.1038/s41565-020-0680-y.
9
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
10
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
N Engl J Med. 2020 Nov 5;383(19):e123. doi: 10.1056/NEJMe2032843.
本文引用的文献
1
The convalescent sera option for containing COVID-19.
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
2
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18. doi: 10.12932/AP-200220-0773.
3
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.
4
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.
5
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.02015-19.
6
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
7
Post-exposure passive immunisation for preventing measles.
Cochrane Database Syst Rev. 2014 Apr 1;2014(4):CD010056. doi: 10.1002/14651858.CD010056.pub2.
8
Use of Concentrated Human Serum gamma-Globulin in the Prevention and Attenuation of Measles.
Bull N Y Acad Med. 1945 Apr;21(4):202-22.
9
Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953.
Am J Public Health. 2005 May;95(5):790-9. doi: 10.2105/AJPH.2004.040790.
10
Infectious hepatitis: current status of prevention with gamma globulin.
Yale J Biol Med. 1961;34(3-4):329-39.
Zotero 插件